Liu Doctor Chief Physician

Peking University Cancer Hospital · Chief Physician

Graduated from Peking University Health Science Center with a Ph.D. in Oncology. Specializes in comprehensive diagnosis and treatment including surgery, chemotherapy, targeted therapy, and immunotherapy for retroperitoneal liposarcoma, retroperitoneal leiomyosarcoma, and other rare soft tissue tumors, gastrointestinal stromal tumors, pancreatic cancer, liver cancer, colorectal cancer liver metastases, and biliary tract malignancies. In 2018, visited The University Hospital of Santiago de Compost

Retroperitoneal tumors, liposarcoma, leiomyosarcoma, gastrointestinal stromal tumor, pancreatic cancer, liver cancer, colorectal cancer liver metastasis, biliary tract malignancy

Liu Doctor
Doctor Photo
Basic Information

About Dr. Liu Doctor

Hospital
Peking University Cancer Hospital
Title
Chief Physician
Department
Years of Practice
28 years (1998 — present)
Graduated from Peking University Health Science Center, Ph.D. in Oncology. Specializes in comprehensive diagnosis and treatment including surgery, chemotherapy, targeted therapy, and immunotherapy for retroperitoneal liposarcoma, retroperitoneal leiomyosarcoma, other rare soft tissue tumors, gastrointestinal stromal tumors, pancreatic cancer, liver cancer, colorectal cancer liver metastases, and biliary tract malignancies. In 2018, visited The University Hospital of Santiago de Compostela, Spain, for academic exchange. In 2017, received the "Liao Kangxiong Scholarship" to visit the General Surgery Team at the University of Minnesota Medical Center, USA, for academic exchange. In 2016, participated in the JENESYS 2.0 Chinese university student delegation to Japan for exchange. In 2016, was invited to participate in the PUHSC-KCL-KEIO-KI Joint Summer Research School at Keio University, Japan, for exchange. Published 12 SCI papers and international conference papers as first author. Participated in key research projects including the Beijing Natural Science Foundation and the Beijing Municipal Administration of Hospitals "Peak Plan" Talent Team Funding Project. Won the National Gold Award in the China Anti-Cancer Association CLEAP Young and Mid-Career Physician Clinical Practice Competition. Won the National Third Prize Team in the Chinese Medical Doctor Association Liver Cancer Treatment Frontiers and Hotspots Debate Competition. Publications 1. D.N. Liu#, L Yan, Z.W. Li, H.Y. Wang, X.Y. Tian, A Lv, C.Y. Hao*: Optimizing surgical strategies for retroperitoneal liposarcoma: a comprehensive evaluation of standardized aggressive surgical policies. BMC Cancer 24:855, 2024 2. W.H. Zhou#, D.N. Liu#, T.H. Fang#, X Chen#, H Jia, X.Y. Tian, C.Y. Hao*, S.H. Yue*: Rapid and Precise Diagnosis of Retroperitoneal Liposarcoma with Deep-Learned Label-Free Molecular Microscopy. Anal Chem, 2024 3. D.N. Liu#, C.Y. Hao*. Reply to letter to the editor re: D.N. Liu, C.P. Li, H.W. Li, et al. volume-based 18F-FDG PET/CT predicts prognosis and outcome of active surveillance for intra-abdominal desmoid tumor, abdominal radiology, 2024. Abdom Radiol (NY), 2024 4. D.N. Liu#, C.P. Li#, H.W. Li, H.Y. Wang, X.Y. Tian, C.Y. Hao*. Volume-based 18F-FDG PET/CT predicts prognosis and outcome of active surveillance for intra-abdominal desmoid tumor. Abdominal Radiology DOI: 10.1007/s00261-023-04145-z, 2024 5. D.N. Liu#, W.J. Hui#, Z.W. Li, H.Y. Wang, X.Y. Tian, C.Y. Hao*. Preoperative assessment of retroperitoneal Liposarcoma using volume-based 18F-FDG PET/CT: implications for surgical strategy and prognosis. BMC Med Imaging 23:215, 2023 6. D.N. Liu#, W.W. Jia#, H.Y. Wang, J.H. Wu, C.P. Li, C.Y. Hao*. Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective study. BMC Surg 23:189, 2023 7. D.N. Liu#, Z.W. Li, H.Y. Wang, M. Zhao, W. Zhao, C.Y. Hao*. Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas. Contrast Media Mol Imaging, 2018; 2018: 2601281, doi:10.1155/2018/2601281. 8. D.N. Liu#, A. Lv, Z.H. Tian, X.Y. Tian, X.Y. Guan, B. Dong, M. Zhao, C.Y. Hao*. Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma. Oncotarget, 2017; 8(5): 7766-7776. 9. D.N. Liu#, J.L. Guo#, Q. Luo, Y. Tian, C.L. Xia, Y.Q. Li*, L. Su*. Location of supraorbital foramen/notch and infraorbital foramen with reference to soft- and hard-tissue landmarks. J Craniofac Surg, 2011; 22(1): 293-296, doi:10.1097/SCS.0b013e3181f7dd74. 10. D.N. Liu#, T.H. Fang#, X. C, K.J. Zhou, J.H. Wu, S.H. Yue*, C.Y. Hao*. Accurate and rapid interoperative assessment of surgical margin in pancreatic ductal adenocarcinoma with AI-assisted stimulated Raman cytology. American Pancreatic Association 2023 Annual Meeting, November 15-18, 2023, Loews Coronado Bay, California. (Poster) 11. D.N. Liu#, Z.H. Tian, X.Y. Tian, X.Y. Guan, B. Dong, M. Zhao, C.Y. Hao*. Tumor Budding in Pancreatic Cancer: a Pathological Phenomenon Represents Cancer Stem Cell and Epithelial–mesenchymal Transition. 50th Annual Meeting of American Pancreatic Association, November 6-9, 2019, Maui, Hawaii. (Poster) 12. Najiha Farooqi#, D.N. Liu#, Greta Berger, Muhammad Maaz, C.Y. Hao*, James V Harmon*. CASTLEMAN'S DISEASE: AN ACUTE CARE SURGEON'S PERSPECTIVE, SAGES & CAGS 16th World Congress of Endoscopic Surgery, April 11-14, 2018, Seattle, WA. (Poster)
Schedule

Dr. Liu Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: Peking University Cancer Hospital · Department
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon Off Duty Off Duty Off Duty
Tue Off Duty Off Duty Off Duty
Wed Off Duty Off Duty Off Duty
Thu Off Duty Off Duty Off Duty
Fri Off Duty On Duty
13:30 - 17:00
Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.
Same-Hospital Doctors

Peking University Cancer Hospital — Oncology Team

More chief-level physicians signed with this hospital.

View all

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WeChat dovecure_care
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult